by Eric Christianson | Sep 25, 2024 | Long Term Care Consultant Pharmacist Education and Information
As a consultant pharmacist, I always try to stay on top of trends to help nursing homes stay on top of guidelines and best practices. With the help of a student, we reviewed 50 LTC facility surveys and share the findings of the most common 2024 nursing home survey...
by Eric Christianson | Sep 22, 2024 | Endocrine Medication and Disease State Clinical Pearls
Fluctuations in blood sugars can be very distressing for patients. This is especially true in patients who have adequate control of their diabetes. Adverse effects can lead to an escalation of diabetes medication. I’ll share my top 5 drugs that cause...
by Eric Christianson | Sep 18, 2024 | Clinical Pharmacy News and New Drug Updates
Neffy is the brand name for intranasal epinephrine that can be used for type I allergic reactions such as anaphylaxis. In this article, we will highlight some of the differences and similarities between Neffy and Epipen. Neffy was approved for patients who weigh over...
by Eric Christianson | Sep 15, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Many drugs cause insomnia. What is most frustrating to me in my practice is when we start medications for a “new condition” prior to ruling out medication adverse effects. Here is the list of my top 5 drugs that cause insomnia (an important adverse...
by Eric Christianson | Sep 11, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
